Gima 24549 Guía De Uso página 5

61
. ‫ﺍﻹﻳﺟﺎﺑﻳﺔ‬ ‫( ﻟﻧﻭﻉ ﺧﺎﺹ ﻣﻥ ﺍﻟﻣﺧﺩﺭﺍﺕ, ﻳﺷﻳﺭ ﺇﻟﻰ ﺍﻟﻧﺗﻳﺟﺔ‬
‫ﻫﺫﺍ ﻳﺷﻳﺭ ﺇﻟﻰ ﺃﻥ ﻧﺳﺑﺔ‬ .‫ﺍﻟﻣﻔﺭﻭﺽ ﻟﺫﻟﻙ ﺍﻟﻧﻭﻉ ﺍﻟﺧﺎﺹ ﻣﻥ ﺍﻟﻣﺧﺩﺭﺍﺕ‬
‫. ﻛﻣﻳﺔ ﻏﻳﺭ ﻛﺎﻓﻳﺔ ﻣﻥ ﻋﻳﻧﺔ ﺍﻟﺑﻭﻝ ﺃﻭ ﺃﺧﻁﺎء ﻓﻲ ﺍﻟﻌﻣﻠﻳﺔ ﻫﻲ ﺍﻷﺳﺑﺎﺏ ﺍﻷﻛﺛﺭ ﺷﻳﻭﻋﺎ ﺍﻟﺗﻲ ﻣﻥ ﺃﺟﻠﻬﺎ ﻣﻥ ﺍﻟﻣﻣﻛﻥ ﺃﻥ‬
.‫ﻭﺍﻻﺗﺻﺎﻝ ﺑﺎﻟﻣﻭﺯ ّ ﻉ ﺍﻟﻣﺣﻠﻲ‬
‫ﻳﻔﺷﻝ ﺍﺍﻟﻔﺣﺹ. ﻣﺭﺍﺟﻌﺔ ﺍﻟﻌﻣﻠﻳﺔ ﻭﺇﻋﺎﺩﺓ ﺍﻟﻔﺣﺹ ﺑﺎﺳﺗﺧﺩﺍﻡ ﻟﻭﺣﺔ ﺷﺭﺍﺋﺢ ﺟﺩﻳﺩﺓ. ﻓﻲ ﺣﺎﻟﺔ ﺩﻭﺍﻡ ﺍﻟﻣﺷﻛﻠﺔ, ﺍﻟﺗﻭﻗﻑ ﻓﻭﺭﺍ ﻋﻥ ﺍﺳﺗﻌﻣﺎﻝ ﺍﻟﻣﺟﻣﻭﻋﺔ‬
‫ﻳ ّﺔ. ﻻ ﺿﺭﻭﺭﺓ ﺇﻟﻰ ﺍﺳﺗﻌﻣﺎﻝ‬ ‫ﺑﻣﻘﺎﺭﻧﺔ ﺍﻷﻟﻭﺍﻥ ﺍﻟﺗﻲ ﺗﻅﻬﺭ ﻓﻲ ﻓﺭﺍﻏﺎﺕ ﺍﻟﻠﻭﺣﺔ ﺍﻟﺗﻔﺎﻋﻠﻳﺔ ﻋﻠﻰ ﺍﻟﺷﺭﺍﺋﺢ ﻣﻊ ﺍﻷﻟﻭﺍﻥ ﺍﻟﻣﺣﺗﻭﻳﺔ ﻓﻲ ﺍﻟﻣﺟﻣﻭﻋﺔ, ﻳﺗﻡ ﺍﻟﺣﺻﻭﻝ ﻋﻠﻰ ﻧﺗﺎﺋﺞ ﺷﺑﻪ ﻛﻣ‬
‫( ﻳﻌﺗﺑﺭ ﺑﻣﺛﺎﺑﺔ ﻋﻣﻠﻳﺔ ﺭﻗﺎﺑﺔ ﺩﺍﺧﻠﻳﺔ. ﻳﺅ ﻛ ّ ﺩ ﻋﻠﻰ ﺃﻥ ﺣﺟﻡ ﺍﻟﻌﻳﻧﺔ ﻛﺎﻑ, ﻭﺑﺄﻥ ﺍﻟﻐﺷﺎء ﻗﺎﻡ‬
‫ﻻ ﺗﺷﻣﻝ ﻣﻌﺎﻳﻳﺭ ﺍﻟﺭﻗﺎﺑﺔ ﺍﻻﻋﺗﻳﺎﺩﻳﺔ؛ ﻭﻣﻊ ﺫﻟﻙ, ﻧﻧﺻﺢ ﺑﺄﻥ ﻳﺗﻡ ﺍﻟﻘﻳﺎﻡ ﺑﺎﻻﺧﺗﺑﺎﺭﺍﺕ ﺍﻟﻣﺧﺗﺑﺭﻳﺔ‬
‫ﺗﺣﻠﻳﻠﻳﺔ ﻓﻘﻁ ﺃﺳﺑﻘﻳﺔ. ﻟﻠﺣﺻﻭﻝ ﻋﻠﻰ ﺗﺄﻛﻳﺩ ﻟﻠﻧﺗﺎﺋﺞ ﺍﻟﺗﺣﻠﻳﻠﻳﺔ ﺍﻟﻣﺣﺻﻭﻝ ﻋﻠﻳﻬﺎ ﻫﻧﺎ, ﻣﻥ‬
5 4 .
.( MS ) ‫ﺍﻟﻛﺗﻠﻲ‬ ‫( ﺃﻭ ﻗﻳﺎﺱ ﺍﻟﻁﻳﻑ‬
.‫ﻣﻥ ﺍﻟﻣﻣﻛﻥ ﺃﻥ ﻳﺣﺩﺙ ﺑﺄﻥ ﺃﺧﻁﺎء ﺗﻘﻧﻳﺔ ﺃﻭ ﺇﺟﺭﺍﺋﻳﺔ, ﻫﻛﺫﺍ ﻣﺛﻝ ﺗﺩﺍﺧﻝ ﻣﻭﺍﺩ ﺃﺧﺭﻯ ﻣﻭﺟﻭﺩﺓ ﻓﻲ ﻋﻳﻧﺔ ﺍﻟﺑﻭﻝ, ﺑﺄﻥ ﺗﺅﺩﻱ ﺇﻟﻰ ﻧﺗﺎﺋﺞ ﺧﺎﻁﺋﺔ‬
‫ﻣﻭﺍﺩ ﻏﺎ ﺷ ّ ﺔ, ﻣﺛﻝ ﻣﺎﺩﺓ ﺍﻟﺗﺑﻳﻳﺽ ﻭ/ﺃﻭ ﺍﻟﺷﺏ, ﺍﻟﻣﻭﺟﻭﺩﺓ ﻓﻲ ﻋﻳﻧﺎﺕ ﺍﻟﺑﻭﻝ ﻣﻥ ﺍﻟﻣﻣﻛﻥ ﺃﻥ ﺗﺅﺩﻱ ﺇﻟﻰ ﻧﺗﺎﺋﺞ ﺧﺎﻁﺋﺔ ﺑﻐﺽ ﺍﻟﻧﻅﺭ ﻋﻥ ﺍﻟﻁﺭﻳﻘﺔ‬
‫ﺍﻟﺗﺣﻠﻳﻠﻳﺔ ﺍﻟﻣﺳﺗﺧﺩﻣﺔ. ﻓﻲ ﺣﺎﻟﺔ‬
.‫ﺑﻭﻝ‬ ‫ﺍﻟﻧﺗﻳﺟﺔ ﺍﻹﻳﺟﺎﺑﻳﺔ ﺗﺷﻳﺭ ﺇﻟﻰ ﻭﺟﻭﺩ ﺍﻟﻣﺧﺩﺭ ﺃﻭ ﺇﻟﻰ ﻭﺟﻭﺩ ﺃﻳﺿﺎﺗﻪ ﻭﻟﻛﻥ ﻻ ﻳﺷﻳﺭ ﺇﻟﻰ ﺩﺭﺟﺔ ﺍﻟﺗﺳﻣﻡ, ﻁﺭﻳﻘﺔ ﺍﻻﺳﺗﻳﻌﺎﺏ, ﺃﻭ ﺇﻟﻰ ﺍﻟﺗﺭﻛﻳﺯ ﻓﻲ ﺍﻟ‬
‫ﻟﻰ ﺑﻭﻝ ﺧﺎﻝ ﻣﻥ ﺍﻟﻣﺧﺩﺭﺍﺕ. ﻣﻥ ﺍﻟﻣﻣﻛﻥ ﺍﻟﺣﺻﻭﻝ ﻋﻠﻰ ﻧﺗﺎﺋﺞ ﺳﻠﺑﻳﺔ ﺃﻳﺿﺎ ﻋﻧﺩﻣﺎ ﺗﻛﻭﻥ ﺍﻟﻣﺧﺩﺭﺍﺕ ﻣﻭﺟﻭﺩﺓ ﻓﻲ ﺍﻟﻌﻳﻧﺔ, ﻭﻟﻛﻥ ﺗﺣﺕ ﻣﺳﺗﻭﻯ‬
‫ﺗﺷﻣﻝ ﻛﺎﻓﺔ ﺍﻟﻣﻭﺍﺩ‬ ‫ﻓﺣﻭﺻﺎﺕ ﻛﺷﻑ ﺍﻟﻐﺵ ّ ﺍﻟﻣﺣﺗﻭﻳﺔ ﻓﻲ ﺍﻟﻣﺟﻣﻭﻋﺔ ﻫﺫﻩ ﻫﺩﻓﻬﺎ ﺍﻟﻣﺳﺎﻋﺩﺓ ﻋﻠﻰ ﺗﺣﺩﻳﺩ ﺍﻟﻌﻳﻧﺎﺕ ﺍﻟﻐﻳﺭ ﻁﺑﻳﻌﻳﺔ. ﺣﺗﻰ ﻭﻟﻭ ﻛﺎﻧﺕ ﺳﻠﻳﻣﺔ, ﻫﺫﻩ ﺍﻟﻔﺣﻭﺻﺎﺕ ﻻ‬
‫. ﻭﺟﻭﺩ ﻣﺳﺗﻭﻳﺎﺕ ﻣﻬﻣﺔ ﻣﻥ ﻣﻘﺎﻭﻣﺎﺕ ﺍﻷﻛﺳﺩﺓ ﻓﻲ ﺍﻟﻌﻳﻧﺔ, ﻣﺛﻝ ﺣﺎﻣﺽ‬
‫ﺇﻟﻰ ﺇﻟﺗﻬﺎﺑﺎﺕ ﻓﻲ ﺍﻟﻣﺳﺎﻟﻙ‬ ‫ﺍﻟﻧﺗﺭﻳﺕ: ﺍﻟﻧﺗﺭﻳﺕ ﻟﻳﺱ ﺑﻣﻛﻭ ّ ﻥ ﺍﻟﺫﻱ ﻳﺗﻭﺍﺟﺩ ﺑﺷﻛﻝ ﻋﺎﻡ ﻓﻲ ﺑﻭﻝ ﺍﻹﻧﺳﺎﻥ. ﻭﻣﻊ ﺫﻟﻙ, ﺁﺛﺎﺭ ﻣﻭﺟﻭﺩﺓ ﻟﻠﻧﺗﺭﻳﺕ ﻓﻲ ﻋﻳﻧﺔ ﺍﻟﺑﻭﻝ ﻣﻥ ﺍﻟﻣﻣﻛﻥ ﺃﻥ ﺗﺷﻳﺭ‬
‫ﻣﻠﻐﻡ / ﺩﺳﻳﻠﻳﺗﺭ ﻣﻥ ﺍﻟﻣﻣﻛﻥ ﺃﻥ ﺗﺅﺩﻱ ﺇﻟﻰ ﻧﺗﺎﺋﺞ ﻣﺯ ﻳ ّﻔﺔ ﺇﻳﺟﺎﺑﻳﺔ ﻋﻠﻰ ﻋﻳﻧﺎﺕ ﻣﻭﺟﻬﺔ ﻟﻛﺷﻑ‬
‫ﻱ ﺍﻟﻐﻳﺭ ﻣﺗﺳ ﻠ ّ ﻁ ﻋﻠﻳﻪ ﺃﻭ‬
‫ﻏﻠﻭﺗﺎﺭ ﺃﻟﺩﻫﻳﺩ: ﺍﻟﺑﻭﻝ ﻻ ﻳﺣﺗﻭﻱ ﺑﺷﻛﻝ ﻋﺎﻡ ﻋﻠﻰ ﻏﻠﻭﺗﺎﺭ ﺃﻟﺩﻫﻳﺩ. ﻣﻊ ﺫﻟﻙ, ﺑﻌﺫ ﺍﻟﺷﺫﻭﺫ ﺍﻷﻳﺿﻳﺔ, ﻣﺛﻼ ﺍﻟﺣﻣﺎﺽ ﺍﻟﻛﻳﺗﻭﻧﻲ )ﺍﻟﺻﻭﻡ, ﻣﺭﺽ ﺍﻟﺳ ﻛ ّ ﺭ‬
.‫ﻣﻠﻐﻡ / ﺩﺳﻳﻠﻳﺗﺭ. ﻓﻲ ﺣﺎﻻﺕ ﻧﺎﺩﺭﺓ, ﺑﻌﺽ ﺍﻷﻣﺭﺍﺽ ﺍﻟﻛﻠﻭﻳﺔ ﻣﻥ ﺍﻟﻣﻣﻛﻥ ﺃﻥ ﺗﺑ ﻳ ّﻥ ﺑﻭﻝ ﻣﺧ ﻔ ّ ﻑ‬
‫ﻋﻳﻧﺔ ﺗﻡ‬ 300 ‫ﺃﺣﺎﺩﻱ ﺍﻟﻁﻭﺭ )ﺑﻭﻝ( ﺗ ﻣ ّ ﺕ ﻣﻘﺎﺭﻧﺗﻪ ﻣﻊ ﻓﺣﻭﺻﺎﺕ ﺃﺧﺭﻯ ﺳﺭﻳﻌﺔ ﻣﺗﻭﻓﺭﺓ ﻓﻲ ﺍﻟﺳﻭﻕ. ﺗﻡ ﺗﻧﻔﻳﺫ ﺍﻟﻔﺣﺹ ﻋﻠﻰ ﻣﺎ ﻳﻘﺎﺭﺏ‬
‫. ﻓﻳﻣﺎ ﻳﻠﻲ ﻣﺑ ﻳ ّﻧﺔ‬ MS / GC ‫ﺍﻟﻣﺯﻋﻭﻣﺔ ﺗﻡ ﺍﻟﺗﺄﻛﻳﺩ ﻋﻠﻳﻬﺎ ﻋﻥ ﻁﺭﻳﻖ‬
Specimen AMP AMP
300 500
Positive >99% *
Negative >99% *
Total >99% *
Specimen THC MTD
150
Positive * >99%
Negative * >99%
Total * >99%
T ) ‫ﻓﻲ ﻓﺭﺍﻍ ﺍﻟﻔﺣﺹ‬
cut-off
.‫ﺍﻟﻣﻔﺭﻭﺽ ﻟﺫﻟﻙ ﺍﻟﻧﻭﻉ ﺍﻟﺧﺎﺹ ﻣﻥ ﺍﻟﻣﺧﺩﺭﺍﺕ‬
.‫ﺍﻟﻼﺯﻣﺔ ﻟﻠﺗﺄﻛﻳﺩ ﺳﻭﺍء ﻋﻠﻰ ﺍﻟﻧﺗﺎﺋﺞ ﺍﻹﻳﺟﺎﺑﻳﺔ ﺃﻭ ﺍﻟﻧﺗﺎﺋﺞ ﺍﻟﺳﻠﺑﻳﺔ, ﻟﻠﺗﺣﻘﻖ ﻣﻥ ﺻﺣﺔ ﺍﻟﻌﻣﻠﻳﺔ ﻭﻣﻥ ﻭﻅﺎﺋﻔﻳﺔ ﺍﻟﻔﺣﺹ‬
GC ) ‫ﺍﻟﺿﺭﻭﺭﻱ ﺍﻟﻠﺟﻭء ﺇﻟﻰ ﻁﺭﻳﻘﺔ ﻛﻳﻣﻳﺎﺋﻳﺔ ﺑﺩﻳﻠﻳﺔ ﺃﻛﺛﺭ ﺗﺣﺩﻳﺩﺍ, ﻣﻥ ﺍﻷﻓﺿﻝ ﺍﻟﻠﺟﻭء ﺇﻟﻰ ﻓﺣﺹ ﺍﻻﺳﺗﺷﺭﺍﺏ ﺍﻟﻐﺎﺯﻱ‬
PCC
. PCC / ‫ﺍﻷﺳﻛﻭﺭﺑﻳﻙ, ﻣﻥ ﺍﻟﻣﻣﻛﻥ ﺃﻥ ﺗﻌﻁﻲ ﻧﺗﺎﺋﺞ ﻣﺯﻳﻔﺔ ﺳﻠﺑﻳﺔ ﻋﻠﻰ ﻋﻳﻧﺎﺕ ﻣﻭ ﺟ ّ ﻬﺔ ﻟﻛﺷﻑ ﺍﻟﻣﻭﺍﺩ ﺍﻟﻣﺅﻛﺳﺩﺓ‬
.‫ﻝ ﻣﻥ ﺍﻟﻣﻣﻛﻥ ﺃﻥ ﺗﺑ ﻳ ّﻥ ﻭﺯﻥ ﻧﻭﻋﻲ ﻋﺎﻝ ﺑﺷﻛﻝ ﻣﻔﺭﻁ‬
‫ﺗﺟﻣﻳﻌﻬﺎ ﺃﺳﺑﻘﻳﺎ ﻣﻥ ﻗﺑﻝ ﺃﺷﺧﺎﺹ ﻣﻭﺟﻭﺩﻳﻥ ﻟﻠﺧﺿﻭﻉ ﺇﻟﻰ ﻓﺣﺹ ﻣﻛﺎﻓﺣﺔ ﺍﻟﻣﺧﺩﺭﺍﺕ. ﺍﻟﻧﺗﺎﺋﺞ ﺍﻹﻳﺟﺎﺑﻳﺔ‬
‫% ﺍﻟﺗﻭﺍﻓﻖ ﻣﻊ ﺍﻟﻣﺟﻣﻭﻋﺔ ﺍﻟﻣﺗﻭﻓﺭﺓ ﻓﻲ ﺍﻟﺳﻭﻕ‬
AMP BAR BZO BZO
200
97% >99% * 90%
>99% 99% * 97%
98% 99% * 94%
EDDP EDDP MET MET
100 300 300 500
* * * >99%
* * * 80%
* * * 87%
ARABIC
‫ﻥ‬ ّ ‫ﺧﻁ ﻣﻠﻭ‬ ‫ﻋﺩﻡ ﻭﺟﻭﺩ‬
‫ﻫﺫﺍ ﻳﺷﻳﺭ ﺇﻟﻰ ﺃﻥ ﻧﺳﺑﺔ ﺗﺭﻛﻳﺯ ﺫﻟﻙ ﺍﻟﻧﻭﻉ ﻣﻥ ﺍﻟﻣﺧﺩﺭﺍﺕ ﻓﻲ ﻋﻳﻧﺔ ﺍﻟﺑﻭﻝ ﺗﻘﻝ ﻋﻥ ﻣﺳﺗﻭﻯ‬
cut-off ‫ﻣﺳﺗﻭﻯ‬
C ) ‫ﻳﺷﻣﻝ ﺍﻟﻔﺣﺹ ﻧﻅﺎﻡ ﺭﻗﺎﺑﺔ ﺃﻭﺗﻭﻣﺎﺗﻳﻛﻲ. ﺍﻟﺧﻁ ﺍﻟﻣﻠﻭ ّ ﻥ ﺍﻟﺫﻱ ﻳﻅﻬﺭ ﻓﻲ ﻓﺭﺍﻍ ﺍﻟﺭﻗﺎﺑﺔ‬
‫ﺑﺎﻣﺗﺻﺎﺹ ﺍﻟﻌﻳﻧﺔ ﻭﺃﻥ ﺍﻟﻌﻣﻠﻳﺔ ﺗﻡ ﺇﻧﺟﺎﺯﻫﺎ ﺑﺎﻟﺷﻛﻝ ﺍﻟﺻﺣﻳﺢ. ﻫﺫﻩ ﺍﻟﻣﺟﻣﻭﻋﺔ‬
‫ﺍﻟﻔﺣﺹ ﺍﻟﻣﺗﻌﺩﺩ ﺍﻟﺧﺎﺹ ﺑﺎﻟﻣﺧﺩﺭﺍﺕ ﺃﺣﺎﺩﻱ ﺍﻟﻁﻭﺭ )ﺑﻭﻝ( ﻳﺯﻭ ّ ﺩ ﻓﻘﻁ ﻧﺗﺎﺋﺞ‬
.‫ﺍﻟﺷﻙ ﺑﻣﺣﺎﻭﻟﺔ ﺍﻟﻐﺵ ّ , ﻳﺟﺏ ﺃﻥ ﻳﻌﺎﺩ ﺍﻟﻔﺣﺹ ﻣﺭﺓ ﺃﺧﺭﻯ ﻋﻠﻰ ﻋﻳﻧﺔ ﺑﻭﻝ ﺃﺧﺭﻯ‬
.‫ﺍﻟﻔﺣﺹ ﻻ ﻳﻔﺭ ّ ﻕ ﺑﻳﻥ ﺍﻟﻣﺧﺩﺭﺍﺕ ﺍﻟﻣﺗﻌﺎﻁﺎﺓ ﻭﺑﻌﺽ ﺍﻷﺩﻭﻳﺔ‬
.‫ﺇﻳﺟﺎﺑﻳﺔ‬ ‫ﺑﻌﺽ ﺍﻟﻣﻭﺍﺩ ﺍﻟﻐﺫﺍﺋﻳﺔ ﺃﻭ ﺍﻟﻣﻛﻣﻼﺕ ﺍﻟﻐﺫﺍﺋﻳﺔ ﻣﻥ ﺍﻟﻣﻣﻛﻥ ﺃﻥ ﺗﺅﺩﻱ ﺇﻟﻰ ﻧﺗﺎﺋﺞ‬
‫: ﺑﻭﻝ ﺍﻹﻧﺳﺎﻥ, ﺑﺷﻛﻝ ﻋﺎﻡ ﻻ ﻳﺣﺗﻭﻱ ﻋﻠﻰ ﻣﻭﺍﺩ ﻣﺅﻛﺳﺩﺓ ﺃﻭ‬
‫ﺍﻟﻭﺯﻥ ﺍﻟﻧﻭﻋﻲ: ﻣﺳﺗﻭﻳﺎﺕ ﻋﺎﻟﻳﺔ ﻣﻥ ﺍﻟﺑﺭﻭﺗﻳﻧﺎﺕ ﻓﻲ ﺍﻟﺑﻭ‬
20 ‫ﻗﻳﻣﺔ‬ ‫ﺍﻟﺑﻭﻟﻳﺔ ﺃﻭ ﺇﻟﺗﻬﺎﺑﺎﺕ ﺳﺑﺑﻬﺎ ﺍﻟﺑﻛﺗﻳﺭﻳﺎ. ﻣﺳﺗﻭﻳﺎﺕ ﻧﺗﺭﻳﺕ ﺍﻟﺗﻲ ﺗﻔﻭﻕ‬
.‫ﻅﺎﻡ ﺍﻷﻛﻝ ﺍﻟﻌﺎﻟﻲ ﺑﺎﻟﺑﺭﻭﺗﻳﻧﺎﺕ( ﻣﻥ ﺍﻟﻣﻣﻛﻥ ﺃﻥ ﺗﺅﺛﺭ ﻋﻠﻰ ﻧﺗﺎﺋﺞ ﺍﻟﻔﺣﺹ‬
350 ‫ﻭ‬ 20 ‫ﺍﻟﻛﺭﻳﺎﺗﻳﻧﻳﻥ: ﺍﻟﻣﺳﺗﻭﻳﺎﺕ ﺍﻟﻌﺎﺩﻳﺔ ﻟﻠﻛﺭﻳﺎﺗﻳﻧﻳﻥ ﺗﺩﻭﺭ ﻣﺎ ﺑﻳﻥ‬
BUP** ACL COC COC
150
88% * >99% 95% >99%
>99% * >99% >99% >99%
97% * >99% 98% >99%
MET MDMA MOP
300 2000
98% >99% >99%
>99% 99% >99% >99%
99% 99% >99% >99%
.‫* ﻣﻼﺣﻅﺔ: ﻣﺟﻣﻭﻋﺔ ﻏﻳﺭ ﻣﺗﻭﻓﺭﺓ ﻓﻲ ﺍﻟﺳﻭﻕ ﻟﻔﺣﺹ ﺍﻟﻣﻘﺎﺭﻧﺔ‬
.‫ﻣﻘﺎﺭﻥ ﻣﻊ ﺍﻻﺳﺗﻳﻌﺎﺏ ﺍﻟﻣﻭﺣﻰ ﺇﻟﻳﻪ ﺫﺍﺗﻳﺎ ﻟﻠﺑﻭﺑﺭﻳﻧﻭﺭﻓﻳﻥ‬
‫( ﻭ‬ C ) ‫ﺧﻁ ﻣﻠﻭ ّ ﻥ ﻓﻲ ﻓﻲ ﻣﻧﻁﻘﺔ ﺍﻟﺭﻗﺎﺑﺔ‬
‫ﺗﻔﻭﻕ‬ ‫ﺗﺭﻛﻳﺯ ﺫﻟﻙ ﺍﻟﻧﻭﻉ ﻣﻥ ﺍﻟﻣﺧﺩﺭﺍﺕ ﻓﻲ ﻋﻳﻧﺔ ﺍﻟﺑﻭﻝ‬
‫: ﻻ ﻳﻅﻬﺭ ﺃﻱ ﺧﻁ ﻓﻲ ﻓﺭﺍﻍ ﺍﻟﺭﻗﺎﺑﺔ‬
‫ﺗﻔﺳﻳﺭ ﻓﺣﺹ ﺍﻟﻣﻭﺍﺩ ﺍﻟﻐﺎ ﺷ ّﺔ‬
(‫)ﻣﺭﺍﺟﻌﺔ ﻻﺋﺣﺔ ﺍﻷﻟﻭﺍﻥ ﺍﻟﻣﺣﺗﻭﻳﺔ ﻓﻲ ﺍﻟﻣﺟﻣﻭﻋﺔ‬
‫ﺍﻟﻧﺗﻳﺟﺔ ﺍﻟﺳﻠﺑﻳﺔ ﻻ ﺗﺷﻳﺭ ﺣﺗﻣﺎ ﺇ‬
.‫ﻟﻠﻔﺣﺹ‬
ّ ‫ﻗﻳﻭﺩ ﺍﻟﻐﺵ‬
PCC / ‫ﺍﻟﻣﻭﺍﺩ ﺍﻟﻣﺅﻛﺳﺩﺓ‬
.‫ﻭﺟﻭﺩ ﻏﻠﻭﺗﺎﺭ ﺃﻟﺩﻫﻳﺩ‬
‫ﺍﻟﻔﺣﺹ ﺍﻟﻣﺗﻌﺩﺩ ﺍﻟﺧﺎﺹ ﺑﺎﻟﻣﺧﺩﺭﺍﺕ‬
COT FTY KET HRN
* * *
* * *
* * *
OPI OXY PCP PPX
99% 96% 98% >99%
99% >99% >99%
98% >99% >99%
:‫ﻧﺗﻳﺟﺔ ﺇﻳﺟﺎﺑﻳﺔ‬
‫ﺔ‬ ‫ﻏﻳﺭ ﺻﺎﻟﺣ‬ ‫ﻧﺗﻳﺟﺔ‬
– T.V.C.
.‫ﺍﻟﻭﺳﺎﺋﻝ ﺍﻹﺿﺎﻓﻳﺔ‬
‫ﺭﻗﺎﺑﺔ ﺍﻟﻛﻳﻔ ﻳ ّ ﺔ‬
‫ﺍﻟﻘﻳﻭﺩ‬
1 .
2 .
3 .
4 .
5 .
cut-off
6 .
7 .
– T.V.C.
1 .
.‫ﺍﻟﻣﻣﻛﻧﺔ ﺍﻟﻐﺎ ﺷ ّ ﺔ‬
2 .
3 .
4 .
5 .
‫ﻧ‬
6 .
‫ﺍﻟﻣﻳﺯﺍﺕ‬
‫ﺍﻟﺩ ﻗ ّ ﺔ‬
:‫ﺟﺩﺍﻭﻝ ﺍﻟﻧﺗﺎﺋﺞ‬
THC THC
20
* 98%
* >99%
* 99%
TRA TCA
* 95%
* >99%
* 99%
BUP :‫ﻣﻼﺣﻅﺔ‬ **